Decrease in noradrenergic activity in hypothalamic nuclei during the development of spontaneous hypertension.
D000818:Animals; D001921:Brain / Q000187:drug effects; D001931:Brain Mapping; D002540:Cerebral Cortex / Q000378:metabolism; D006973:Hypertension / Q000378:metabolism*; D007031:Hypothalamus / Q000378:metabolism*; D008297:Male; D008526:Medulla Oblongata / Q000378:metabolism; D008636:Mesencephalon / Q000378:metabolism; D008781:Methyltyrosines / Q000494:pharmacology; D009474:Neurons / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism*; D051381:Rats
D008781:Methyltyrosines; D009638:Norepinephrine